secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001372514-25-000003
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora formalizes employment agreements with CFO and CDO; base salaries $337K and $443K
--------------------------------------------------------------------------------

- Eric Daniels (CDO) receives $443,000 annual base salary, 40% bonus target, and $6,500/month relocation gross-up for 15 months.
- Melissa Tosca (CFO) receives $337,000 annual base salary, 40% bonus target, and severance of 6 months' salary plus 0.5x max bonus.
- Both agreements provide full equity acceleration upon a change of control and partial vesting on qualifying termination.
- Daniels must reimburse 50% of relocation costs if he resigns or is fired for cause within 12 months.
- Agreements executed January 10, 2025, effective January 1, 2025, for Daniels and formalizing Tosca's promotion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251425000003/0001372514-25-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251425000003/kprx-20250110.htm
  HTML page:      https://secwatch.observer/filing/0001372514-25-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer